Literature DB >> 30506213

Predicting response to somatostatin analogues in acromegaly: machine learning-based high-dimensional quantitative texture analysis on T2-weighted MRI.

Burak Kocak1, Emine Sebnem Durmaz2, Pinar Kadioglu3, Ozge Polat Korkmaz3, Nil Comunoglu4, Necmettin Tanriover5, Naci Kocer2, Civan Islak2, Osman Kizilkilic2.   

Abstract

OBJECTIVE: To investigate the value of machine learning (ML)-based high-dimensional quantitative texture analysis (qTA) on T2-weighted magnetic resonance imaging (MRI) in predicting response to somatostatin analogues (SA) in acromegaly patients with growth hormone (GH)-secreting pituitary macroadenoma, and to compare the qTA with quantitative and qualitative T2-weighted relative signal intensity (rSI) and immunohistochemical evaluation.
METHODS: Forty-seven patients (24 responsive; 23 resistant patients to SA) were eligible for this retrospective study. Coronal T2-weighted images were used for qTA and rSI evaluation. The immunohistochemical evaluation was based on the granulation pattern of the adenomas. Dimension reduction was carried out by reproducibility analysis and wrapper-based algorithm. ML classifiers were k-nearest neighbours (k-NN) and C4.5 algorithm. The reference standard was the biochemical response status. Predictive performance of qTA was compared with those of the quantitative and qualitative rSI and immunohistochemical evaluation.
RESULTS: Five hundred thirty-five out of 828 texture features had excellent reproducibility. For the qTA, k-NN correctly classified 85.1% of the macroadenomas regarding response to SAs with an area under the receiver operating characteristic curve (AUC-ROC) of 0.847. The accuracy and AUC-ROC ranges of the other methods were 57.4-70.2% and 0.575-0.704, respectively. Differences in predictive performance between qTA-based classification and the other methods were significant (p < 0.05).
CONCLUSIONS: The ML-based qTA of T2-weighted MRI is a potential non-invasive tool in predicting response to SAs in patients with acromegaly and GH-secreting pituitary macroadenoma. The method performed better than the qualitative and quantitative rSI and immunohistochemical evaluation. KEY POINTS: • Machine learning-based texture analysis of T2-weighted MRI can correctly classify response to somatostatin analogues in more than four fifths of the patients. • Machine learning-based texture analysis performs better than qualitative and quantitative evaluation of relative T2 signal intensity and immunohistochemical evaluation. • About one third of the texture features may not be excellently reproducible, indicating that a reliability analysis is necessary before model development.

Entities:  

Keywords:  Acromegaly; Growth hormone-secreting pituitary adenoma; Machine learning; Magnetic resonance imaging; Somatostatin

Mesh:

Substances:

Year:  2018        PMID: 30506213     DOI: 10.1007/s00330-018-5876-2

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  20 in total

1.  Influence of MRI acquisition protocols and image intensity normalization methods on texture classification.

Authors:  G Collewet; M Strzelecki; F Mariette
Journal:  Magn Reson Imaging       Date:  2004-01       Impact factor: 2.546

2.  Intensity of pituitary adenoma on T2-weighted magnetic resonance imaging predicts the response to octreotide treatment in newly diagnosed acromegaly.

Authors:  Ansgar Heck; Geir Ringstad; Stine L Fougner; Olivera Casar-Borota; Terje Nome; Jon Ramm-Pettersen; Jens Bollerslev
Journal:  Clin Endocrinol (Oxf)       Date:  2012-07       Impact factor: 3.478

3.  Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study.

Authors:  Ming Shen; Xuefei Shou; Yongfei Wang; Zhaoyun Zhang; Jinsong Wu; Ying Mao; Shiqi Li; Yao Zhao
Journal:  Endocr J       Date:  2010-11-16       Impact factor: 2.349

4.  Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial.

Authors:  Zhi-gang Mao; Yong-hong Zhu; Hai-liang Tang; Dao-yuan Wang; Jing Zhou; Dong-sheng He; Hai Lan; Bai-ning Luo; Hai-jun Wang
Journal:  Eur J Endocrinol       Date:  2010-01-08       Impact factor: 6.664

5.  Magnetic resonance imaging as a predictor of response to somatostatin analogs in acromegaly after surgical failure.

Authors:  Manel Puig-Domingo; Eugenia Resmini; Beatriz Gomez-Anson; Joana Nicolau; Mireia Mora; Elisabet Palomera; Camelia Martí; Irene Halperin; Susan M Webb
Journal:  J Clin Endocrinol Metab       Date:  2010-08-25       Impact factor: 5.958

6.  N4ITK: improved N3 bias correction.

Authors:  Nicholas J Tustison; Brian B Avants; Philip A Cook; Yuanjie Zheng; Alexander Egan; Paul A Yushkevich; James C Gee
Journal:  IEEE Trans Med Imaging       Date:  2010-04-08       Impact factor: 10.048

Review 7.  Magnetic resonance imaging of pituitary adenomas.

Authors:  Jean-François Bonneville; Fabrice Bonneville; Françoise Cattin
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

8.  Clinicopathological features of growth hormone-producing pituitary adenomas: difference among various types defined by cytokeratin distribution pattern including a transitional form.

Authors:  Abdulkader Obari; Toshiaki Sano; Kenichi Ohyama; Eiji Kudo; Zhi Rong Qian; Akiko Yoneda; Nasim Rayhan; Muhammad Mustafizur Rahman; Shozo Yamada
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

9.  Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial.

Authors:  Sven M Carlsen; Morten Lund-Johansen; Thomas Schreiner; Sylvi Aanderud; Oivind Johannesen; Johan Svartberg; John G Cooper; John K Hald; Stine L Fougner; Jens Bollerslev
Journal:  J Clin Endocrinol Metab       Date:  2008-05-20       Impact factor: 5.958

10.  Bias in error estimation when using cross-validation for model selection.

Authors:  Sudhir Varma; Richard Simon
Journal:  BMC Bioinformatics       Date:  2006-02-23       Impact factor: 3.169

View more
  14 in total

Review 1.  Radiomics with artificial intelligence: a practical guide for beginners.

Authors:  Burak Koçak; Emine Şebnem Durmaz; Ece Ateş; Özgür Kılıçkesmez
Journal:  Diagn Interv Radiol       Date:  2019-11       Impact factor: 2.630

Review 2.  Machine Learning in Pituitary Surgery.

Authors:  Vittorio Stumpo; Victor E Staartjes; Luca Regli; Carlo Serra
Journal:  Acta Neurochir Suppl       Date:  2022

Review 3.  Application of artificial intelligence and radiomics in pituitary neuroendocrine and sellar tumors: a quantitative and qualitative synthesis.

Authors:  Kelvin Koong; Veronica Preda; Anne Jian; Benoit Liquet-Weiland; Antonio Di Ieva
Journal:  Neuroradiology       Date:  2021-11-27       Impact factor: 2.804

4.  The therapeutic response of somatotropinomas according to the T2-weighted signal intensity on the MRI.

Authors:  Carla-Liana Scânteie; Daniel-Corneliu Leucuţa; Cristina Ghervan
Journal:  Med Pharm Rep       Date:  2021-10-30

5.  Prediction of high proliferative index in pituitary macroadenomas using MRI-based radiomics and machine learning.

Authors:  Lorenzo Ugga; Renato Cuocolo; Domenico Solari; Elia Guadagno; Alessandra D'Amico; Teresa Somma; Paolo Cappabianca; Maria Laura Del Basso de Caro; Luigi Maria Cavallo; Arturo Brunetti
Journal:  Neuroradiology       Date:  2019-08-02       Impact factor: 2.804

Review 6.  Machine learning applications in imaging analysis for patients with pituitary tumors: a review of the current literature and future directions.

Authors:  Ashirbani Saha; Samantha Tso; Jessica Rabski; Alireza Sadeghian; Michael D Cusimano
Journal:  Pituitary       Date:  2020-06       Impact factor: 4.107

7.  A systematic review on machine learning in sellar region diseases: quality and reporting items.

Authors:  Nidan Qiao
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

8.  Prediction of pituitary adenoma surgical consistency: radiomic data mining and machine learning on T2-weighted MRI.

Authors:  Renato Cuocolo; Lorenzo Ugga; Domenico Solari; Sergio Corvino; Alessandra D'Amico; Daniela Russo; Paolo Cappabianca; Luigi Maria Cavallo; Andrea Elefante
Journal:  Neuroradiology       Date:  2020-07-23       Impact factor: 2.804

9.  Radiomics Approach for Prediction of Recurrence in Non-Functioning Pituitary Macroadenomas.

Authors:  Yang Zhang; Ching-Chung Ko; Jeon-Hor Chen; Kai-Ting Chang; Tai-Yuan Chen; Sher-Wei Lim; Yu-Kun Tsui; Min-Ying Su
Journal:  Front Oncol       Date:  2020-12-18       Impact factor: 6.244

10.  Usefulness of the Texture Signatures Based on Multiparametric MRI in Predicting Growth Hormone Pituitary Adenoma Subtypes.

Authors:  Chen-Xi Liu; Li-Jun Heng; Yu Han; Sheng-Zhong Wang; Lin-Feng Yan; Ying Yu; Jia-Liang Ren; Wen Wang; Yu-Chuan Hu; Guang-Bin Cui
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.